Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Interim safety analysis from a randomized, open-label, multicenter, phase III trial of capecitabine plus oxaliplatin (XELOX) versus capecitabine (X) as first-line chemotherapy in elderly patients with advanced gastric cancer (AGC).
- Authors
- Hwang, IG[Hwang, In Gyu]; Kang, JH[Kang, Jung Hun]; Lee, S[Lee, Soonil]; Lee, HR[Lee, Hyo Rak]; Lee, HY[Lee, Hui Young]; Ji, JH[Ji, Jun Ho]; Lee, J[Lee, Jeeyun]; Park, SH[Park, Se Hoon]; Park, JO[Park, Joon Oh]; Park, YS[Park, Young Suk]; Lim, HY[Lim, Ho Yeong]; Kang, WK[Kang, Won Ki]
- Issue Date
- 20-Jan-2014
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.32, no.3
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 32
- Number
- 3
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.